1 | ACE I, ATA II and Statins | - | - | - | - | 1件: 218 218 |
2 | ACE-inhibitor | - | - | - | - | 1件: 218 218 |
3 | AT1-inhibitor | - | - | - | - | 1件: 218 218 |
4 | ATRASENTAN | 1件: Atrasentan Atrasentan | - | - | - | 3件: 66 66, 218, 222 |
5 | Bardoxolone | 1件: Bardoxolone Bardoxolone | 1件: D09584
D09584
| - | - | 7件: 66 66, 67, 84, 85, 86, 218, 222 |
6 | Bardoxolone methyl | 2件: Bardoxolone Bardoxolone, Bardoxolone methyl | 2件: D09584
D09584
,
D09585
| - | - | 7件: 66 66, 67, 84, 85, 86, 218, 222 |
7 | Benazepril | 1件: Benazepril Benazepril | 2件: D00620
D00620
,
D07499
| 1件: ACE ACE 💬 | 6件: Chagas disease Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬 | 4件: 49 49, 57, 218, 224 |
8 | Benazepril hydrochloride 10 milligram (mg) Tab | 1件: Benazepril Benazepril | 2件: D00620
D00620
,
D07499
| 1件: ACE ACE 💬 | 6件: Chagas disease Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬 | 1件: 218 218 |
9 | Benazepril, Valsartan and Fluvastatin | 3件: Benazepril Benazepril, Fluvastatin, Valsartan | 5件: D00400
D00400
,
D00620
,
D00892
,
D07499
,
D07983
| 3件: ACE ACE, AGTR1, HMGCR 💬 | 22件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Bile secretion, Calcium signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Terpenoid backbone biosynthesis, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 218 218 |
10 | Delix | - | - | - | - | 1件: 218 218 |
11 | Fluvastatin | 1件: Fluvastatin Fluvastatin | 2件: D00892
D00892
,
D07983
| 1件: HMGCR HMGCR 💬 | 4件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | 3件: 79 79, 218, 222 |
12 | Gold | 1件: Gold Gold | - | - | - | 43件: 2 2, 5, 6, 13, 17, 34, 35, 46, 49, 50, 53, 58, 65, 68, 76, 84, 86, 91, 93, 95, 96, 97, 98, 113, 137, 158, 162, 171, 193, 218, 222, 224, 227, 230, 235, 271, 291, 294, 296, 298, 299, 310, 318 |
13 | HMG-Coenzyme inhibitor (statin) | - | - | - | - | 1件: 218 218 |
14 | Hydroxychloroquine | 1件: Hydroxychloroquine Hydroxychloroquine | 1件: D08050
D08050
| - | - | 27件: 13 13, 34, 41, 43, 44, 45, 46, 48, 49, 53, 56, 63, 66, 84, 89, 90, 96, 97, 107, 218, 222, 224, 234, 254, 271, 298, 299 |
15 | Hydroxychloroquine Sulfate 100 milligram (mg) Tab | 2件: Hydroxychloroquine Hydroxychloroquine, Sulfate ion | 1件: D08050
D08050
| - | - | 1件: 218 218 |
16 | Lademirsen | - | - | - | - | 1件: 218 218 |
17 | Lademirsen (SAR339375) | - | - | - | - | 1件: 218 218 |
18 | Paricalcitol | 1件: Paricalcitol Paricalcitol | 1件: D00930
D00930
| 1件: VDR VDR 💬 | 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 4件: 19 19, 66, 218, 238 |
19 | R3R01 | - | - | - | - | 2件: 218 218, 222 |
20 | Ramipril | 1件: Ramipril Ramipril | 1件: D00421
D00421
| 1件: ACE ACE 💬 | 6件: Chagas disease Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬 | 7件: 46 46, 49, 66, 67, 113, 218, 257 |
21 | RE-021 | - | - | - | - | 3件: 66 66, 218, 222 |
22 | RG-012 | - | - | - | - | 1件: 218 218 |
23 | RG012 | - | - | - | - | 1件: 218 218 |
24 | RTA 402 | - | - | - | - | 3件: 67 67, 86, 218 |
25 | SAR339375 | - | - | - | - | 1件: 218 218 |
26 | SPARSENTAN | 1件: Sparsentan Sparsentan | 1件: D11776
D11776
| 2件: AGTR1 AGTR1, EDNRA 💬 | 17件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 3件: 66 66, 218, 222 |
27 | Spironolactone | 1件: Spironolactone Spironolactone | 1件: D00443
D00443
| 1件: NR3C2 NR3C2 💬 | 1件: Aldosterone-regulated sodium reabsorption Aldosterone-regulated sodium reabsorption 💬 | 7件: 58 58, 67, 86, 113, 210, 218, 225 |
28 | Sulfate | 1件: Sulfate ion Sulfate ion | - | - | - | 27件: 2 2, 3, 6, 11, 13, 26, 28, 34, 36, 46, 49, 53, 60, 64, 66, 79, 85, 86, 96, 111, 218, 222, 226, 265, 296, 297, 299 |
29 | Valsartan | 1件: Valsartan Valsartan | 1件: D00400
D00400
| 1件: AGTR1 AGTR1 💬 | 16件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 7件: 57 57, 58, 66, 75, 218, 222, 224 |